missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Protein Analysis Reagents
  4. Bioactive Small Molecules
  5. 30021997

Tocris Bioscience™ Y-27632 dihydrochloride

Product Code. 30021997
Change view
Click to view available options
Quantity:
10 mg
Unit Size:
10mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Product Code. Quantity unitSize
30021997 10 mg 10mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Product Code. 30021997 Supplier Tocris Bioscience™ Supplier No. TB1254GMP/10
  • ONLINE EXCLUSIVE PRICE
    1540.00€
    1452.15€ / 10mg
    Save 87.85€
    5% Off
 Restricted Item
In Stock
Add to basket
Add to basket
This item is not returnable. View return policy

Description

Y-27632 synthesized to cGMP guidelines

Y-27632 dihydrochloride is a Y-27632 synthesized to cGMP guidelines. Suitable for use as an ancillary reagent in the further manufacturing of cell therapies.

For more information about how Y-27632 may be used, please see our protocols: Transdifferentiating Fibroblasts into Neurons, Converting Fibroblasts into Cardiomyocytes (9C Cocktail), Accelerated Induction of Cortical Neurons from hiPSCs, Human iPSC-derived Myoblasts .

Research use only Y-27632 also available.

TRUSTED_SUSTAINABILITY

Specifications

Chemical Name or Material trans-4-[(1R)-1-Aminoethyl]-N-4-pyridinylcyclohexanecarboxamide dihydrochloride
CAS 129830-38-2
Quantity 10 mg
Target Rho-kinase Inhibitors
Molecular Formula C14H21N3O.2HCl
Purity 99%
Regulatory Status GMP
Produkttitel
Vælg et problem

Ved at klikke på Send, anerkender du, at du kan blive kontaktet af Fisher Scientific med hensyn til den feedback, du har givet i denne formular. Vi deler ikke dine oplysninger til andre formål. Alle angivne kontaktoplysninger skal også vedligeholdes i overensstemmelse med vores Privatlivspolitik.